Press Releases–2013

CenterWatch Commemorative April Issue Profiles 20 Innovators Transforming the Clinical Trials Industry

Boston, April 1, 2013—CenterWatch, a leading provider of global clinical trials information, is marking the 20th anniversary of its flagship publication The CenterWatch Monthly with a special commemorative issue "20 Innovators Changing the Face of the Clinical Trials Industry." This issue focuses on 20 innovators disrupting and transforming the drug development paradigm.

"For the past 20 years, The CenterWatch Monthly has monitored the pulse of the clinical trials industry," said Cheryl Rosenfeld, editor-in-chief of CenterWatch. "Based on rigorous quantitative and qualitative analysis and in-depth reporting, The CenterWatch Monthly has identified new trends, uncovered practices causing unintended consequences, and revealed new solutions and practices to improve clinical research performance, efficiency and cost." Rosenfeld said that this commemorative issue highlights pioneering innovations that will lead the industry into the next decade and beyond.

Drug developers share a growing concern that the current R&D paradigm is unsustainable—high and rising costs and increasing scientific and operating complexity undermine the industry's ability to successfully develop new medicines. At the same time, public trust in the pharmaceutical industry, which relies on patient volunteers to test drugs in development, has eroded.

Although the industry is notoriously resistant to change, forward-thinking leaders realize they must explore new approaches in order to transform drug development and revitalize the industry. Many of the new approaches involve collaboration, which can be more efficient, quicker and can achieve better outcomes than R&D centered in pharmaceutical companies.

"From collaboration to crowdsourcing to consolidation, these innovations and the people behind them truly are making a difference," said Joan Chambers, chief operating officer of CenterWatch. "At every phase of development—from early R&D to study conduct to post-approval—innovators share a common vision: to engage patients and other stakeholders as partners in the process to deliver new treatments to patients more quickly, safely and efficiently."

To learn more about the top 20 innovators, purchase the commemorative April issue or subscribe to The CenterWatch Monthly.

About CenterWatch

Since 1994, CenterWatch, has been the recognized global leader in providing clinical trials information to a broad and influential spectrum of clinical research professionals ranging from top sponsors and CROs to research sites and niche providers, as well as an engaged population of patients interested in clinical research and volunteering. For more information, visit www.centerwatch.com.

Contact:

Cheryl Appel Rosenfeld
Editor-in-Chief, CenterWatch
cheryl.rosenfeld@centerwatch.com
(617) 948-5172